Skip to main content
OpenTrials
Completed

NCT Number: NCT05700812

IUD Placement Without Sounding

The purpose of this study is to determine the feasibility of a uterine sound sparing technique for levonorgestrel 52 mg intrauterine device (IUD) placement. This study will be conducted in three phases. In phase one, the IUD will be placed in standard fashion with a uterine sound to obtain baseline data. Phase two and three are interventional phases that will investigate IUD placement without the use of a uterine sound. In phase two, the IUD will be placed without the use of a uterine sound, but under abdominal ultrasound guidance. In phase three, the IUD will be placed without the use of a uterine sound and without ultrasound guidance. An ultrasound exam will be completed at the end of phase two and three to determine if the IUD was successful placed. To answer the secondary objectives, for all study phases the investigators will measure the procedure time, the participant-reported maximum pain during and 5-minutes post placement and the provider assessment of ease of placement. To determine the exploratory objective of IUD expulsion and perforation rate for a uterine sound sparing IUD placement technique, participants in phases two and three will complete a 30-day phone follow up and 90-day in clinic follow up to evaluate for IUD expulsion or perforation. The investigators hypothesize that the levonorgestrel 52 mg IUD can successfully be inserted without uterine sounding.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

IUD IUD Insertion Complication IUD; Complications

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of California Davis

Sacramento, California, 95817, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • Patients undergoing a levonorgestrel 52 mg IUD placement for contraception at a UC Davis outpatient clinic, who have signed consent for placement and are candidates for levonorgestrel 52 mg IUD placement based on the clinical judgement of their UC Davis Ob-Gyn provider.

Exclusion criteria

  • Women with prior failed IUD placement
  • Women with known uterine anomalies or uterine fibroids that distort the uterine cavity
  • Women with known cervical stenosis

Treatment and study plan

Sound sparing levonorgestrel 52 mg IUD placement

Procedure

In phase one, the IUD will be placed in a standard fashion with the use of a uterine sound to obtain baseline data.

In the experimental phases of the study (phase 2 and 3) the levonorgestrel 52 mg IUD will be placed without the use of a uterine sound. In phase 2 the IUD will be placed under abdominal ultrasound guidance. In phase 3 the IUD will be placed without abdominal ultrasound guidance.

Primary outcomes

  1. Successful placement, defined by ultrasound confirmation, of a levonorgestrel 52 mg IUD placement without uterine sounding.

    Time frame: Ultrasound completed at end of IUD placement procedure to determine if successfully placed in the correct location.

    Successful placement without a uterine sound defined as ultrasound confirmation of IUD in the uterine cavity following placement. Outcomes will be compared between experimental phases two and three.

Secondary outcomes

  1. Total time of IUD placement measured in minutes

    Time frame: Measured once on day of IUD placement

    Time measured from the start of the IUD inserter touching the cervix to the removal of the IUD inserter from the cervix in each of the three phases of the study. Outcomes will be compared for each of the three phases.

  2. Participant-reported maximum pain during IUD placement measured with a 100-mm visual analog scale

    Time frame: Measured once on day of IUD placement

    Participants will be handed a 100-mm visual analog scale and asked to mark their pain level. The assessment will be performed immediately following removal of IUD inserter and before the IUD thread is cut. Outcomes will be compared for each of the three phases.

  3. Participant-reported pain 5-minutes post IUD placement, meaured with a 100-mm visual analog scale

    Time frame: Measured once on day of IUD placement

    Participants will be handed a 100-mm visual analog scale and asked to mark their pain level. The assessment will be performed five minutes following removal of the speculum at the end of IUD placement procedure. Outcomes will be compared for each of the three phases.

  4. Provider assessment of ease of placement defined as an easy, moderate or difficult placement.

    Time frame: Measured once on day of IUD placement

    Providers placing the IUD will be asked to rate their assessment of the the ease of the IUD placement procedure as easy, moderate or difficult after completing IUD placement procedure. Outcomes will be compared for each of the three phases.

  5. IUD expulsion and perforation rate during first three months after placement with sound-sparing technique

    Time frame: Measured at time of IUD insertion and three month clinic follow up three months after IUD placement

    An ultrasound exam will be completed on the day of the IUD placement to determine if the IUD is present in the uterine cavity and not perforated outside of the uterine cavity or expelled out of the uterine cavity. Outcomes will be reported for participants in phases two and three.

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Registry information

Official study title

Feasibility Study of IUD Placement Without Sounding

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Jan 26, 2023
Registry last updated
Aug 7, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.